Biogen Inc (BIIB)

Index:

Nasdaq 100

$ 223.97
   
  • Change Today:
    $0.78
  • 52 Week High: $285.89
  • 52 Week Low: $190.52
  • Currency: US Dollars
  • Shares Issued: 144.90m
  • Volume: 220,095
  • Market Cap: $32,452m
  • RiskGrade: 259

US broker round-up

Date: Tuesday 09 Apr 2013

LONDON (ShareCast) - Top US stock recommendations of the day:

BAKER HUGHES: RBC Capital Mkts reiterates HOLD rating, price target of $50 (vs. $48).

BIOGEN: RBC Capital Mkts reiterates OVERWEIGHT rating, price target of $215 (vs. $180).

BOEING: Aurgus reiterates BUY rating, price target of $96 (vs. $88).

CENTURYLINK: Deutsche Bank Securities initiates coverage at HOLD.

GILEAD SCIENCES: RBC Capital Mkts reiterates OVERWEIGHT rating, price target of $55 (vs. $50).

INTUITIVE SURGICAL: WallachBEth Capital initiates coverage at BUY, price target of $610.

MONSANTO: Stifel Nicolaud initiates coverage at HOLD.

ST JUDE MEDICAL: RBC downgrades to UNDERWEIGHT from hold.

CS

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Biogen Inc Market Data

Currency US Dollars
Share Price $ 223.97
Change Today $ 0.78
% Change 0.35 %
52 Week High $285.89
52 Week Low $190.52
Volume 220,095
Shares Issued 144.90m
Market Cap $32,452m
RiskGrade 259

What The Brokers Say

Strong Buy 9
Buy 14
Neutral 11
Sell 0
Strong Sell 0
Total 34
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 26-Jun-2024

Time Volume / Share Price
11:29 100 @ $223.97
11:29 100 @ $223.97
11:29 136 @ $223.92
11:29 200 @ $223.57
11:28 100 @ $223.57

Top of Page